109 related articles for article (PubMed ID: 11436501)
1. [Antimicrobial activities of meropenem against clinically isolated strains in 1999].
Suzuki Y; Nishinari C; Endo H; Tamura C
Jpn J Antibiot; 2001 Apr; 54(4):145-70. PubMed ID: 11436501
[TBL] [Abstract][Full Text] [Related]
2. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2004].
Yamaguchi K; Murakami M; Takahashi A; Ishii Y; Iwata M; Itoh K; Oohara T; Watanabe N; Uehara N; Nomura F; Watanabe M; Yasujima M; Kasai T; Kanno H; Aihara M; Suwabe A; Yamahata K; Maesaki S; Hashikita G; Kaku M; Kanemitsu K; Miyake K; Oguri T; Yoshida H; Nishiyama K; Okada J; Tazawa Y; Komatsu M; Nakashima H; Takemura H; Kinoshita S; Okada M; Kobayashi S; Taminato T; Negayama K; Horii T; Murase M; Miyamoto H; Baba H; Kusano N; Mihara E; Ishigo S; Kambe M; Itaha H; Fujita N; Komori T; Ono J; Yoshimura H; Ichiyama S; Maeda S; Hirakata Y; Matsuda J; Yamanaka K; Mutara Y; Saikawa T; Hiramatsu K; Taminato S
Jpn J Antibiot; 2005 Dec; 58(6):655-89. PubMed ID: 16521347
[TBL] [Abstract][Full Text] [Related]
3. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009].
Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Shinagawa M; Yasujima M; Suwabe A; Kuroda M; Kaku M; Kitagawa M; Kanemitsu K; Imafuku Y; Murakami M; Yomodu S; Taniguchi N; Yamada T; Nomura F; Kanno H; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Horikawa Y; Maekawa M; Nagura O; Yagi T; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kawano S; Kinoshita S; Taminato T; Negayama K; Murase M; Miyamoto H; Kusano N; Nose M; Yokozaki M; Itaha H; Matsunaga A; Yoshimura H; Kohno S; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
Jpn J Antibiot; 2011 Apr; 64(2):53-95. PubMed ID: 21721247
[TBL] [Abstract][Full Text] [Related]
4. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006].
Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Uehara N; Yasujima M; Kasai T; Suwabe A; Yamahata K; Kaku M; Kanemitsu K; Imafuku Y; Nishiyama K; Murakami M; Yomoda S; Taniguchi N; Yamada T; Nomura F; Watanabe M; Kanno H; Aihara M; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Yamazaki F; Horii T; Maekawa M; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Iinuma Y; Maeda S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kinoshita S; Fujita J; Negayama K; Murase M; Miyamoto H; Kusano N; Mihara E; Itaha H; Ono J; Yoshimura H; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
Jpn J Antibiot; 2007 Dec; 60(6):344-77. PubMed ID: 18447206
[TBL] [Abstract][Full Text] [Related]
5. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2002].
Yamaguchi K; Ishii Y; Iwata M; Yoshida H; Satoh T; Watanabe N; Uehara N; Murakami M; Takahashi A; Yasujima M; Kasai T; Itoh K; Shibuya Y; Suwabe A; Obata R; Kanno H; Kubo S; Kaku M; Kanemitsu K; Maesaki S; Hashikita G; Igari J; Oguri T; Aihara M; Kinoshita S; Okada J; Tazawa Y; Taminato T; Negayama K; Nakashima H; Takemura H; Murase M; Miyamoto H; Horii T; Kusano N; Mihara E; Baba H; Ishigo S; Kambe M; Itaha H; Fujita N; Komori T; Ono J; Yoshimura H; Ichiyama S; Maeda S; Hirakata Y; Matsuda J; Yamanaka K; Murata Y; Saikawa T; Hiramatsu K
Jpn J Antibiot; 2004 Feb; 57(1):70-104. PubMed ID: 15116574
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Kinoshita S; Kumagai S
Jpn J Antibiot; 1998 Sep; 51(9):551-60. PubMed ID: 9846282
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial activities of meropenem against clinically isolated strains].
Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1996 Feb; 49(2):175-93. PubMed ID: 8721078
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial activities of meropenem against clinically isolated strains in 1997].
Suzuki Y; Matsumoto Y; Nishinari C; Endo H; Ishihara R; Deguchi K
Jpn J Antibiot; 1999 Dec; 52(12):695-720. PubMed ID: 10695025
[TBL] [Abstract][Full Text] [Related]
9. [In-vitro activity of panipenem against clinical isolates in 2006].
Yoshida S; Koga T; Kakuta M; Kobayashi I; Matsuzaki K; Urabe E; Omika K; Hasegawa M; Sato Y
Jpn J Antibiot; 2008 Feb; 61(1):1-17. PubMed ID: 18536215
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
Abe T; Fukuoka T; Sato Y; Ito K; Sei M
Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628
[TBL] [Abstract][Full Text] [Related]
12. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012].
Yamaguchi K; Ishii Y; Tateda K; Iwata M; Watanabe N; Shinagawa M; Kayaba H; Kimura M; Suwabe A; Kaku M; Abe Y; Kanemitsu K; Taniguchi N; Murakami M; Maesaki S; Kawamura T; Nomura F; Watanabe M; Kanno H; Horiuchi H; Tazawa Y; Kondo S; Misawa S; Takemura H; Nakashima H; Matsuto T; Fujimoto Y; Ishigo S; Gotoh H; Watanabe O; Yagi T; Shimaoka N; Mikamo H; Yamagishi Y; Fujita N; Komori T; Ichiyama S; Kawano S; Nakayama A; Nakamura F; Kohno H; Fukuda S; Kusano N; Nose M; Yokozaki M; Onodera M; Murao K; Negayama K; Nishimiya T; Miyamoto H; Matsunaga A; Yoshimura H; Kohno S; Yanagihara K; Hiramatsu K
Jpn J Antibiot; 2014 Apr; 67(2):73-107. PubMed ID: 24956909
[TBL] [Abstract][Full Text] [Related]
13. [Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents].
Igari J; Watanabe N; Uehara N; Inoue M; Yoshida H; Imafuku Y; Nishino T; Shibano T; Satou S; Kobayashi I; Takahashi A; Yomoda S; Matsuoka K; Oguri T; Ohba Y; Kumasaka K; Tokuda K; Kobayashi Y; Hongo T; Okada J; Sasaki T; Matsumoto N; Hirata Y; Nakasaki N; Ono J; Takata T; Kawaguchi R; Ohtaki Y; Kajimura K; Ishigo S; Hashimoto T; Aoki N; Okamoto E; Murakami E; Saeki H
Jpn J Antibiot; 2000 Mar; 53(3):157-70. PubMed ID: 10834147
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activity of biapenem against recent clinical isolates].
Hara T; Araake M; Watabe H
Jpn J Antibiot; 2003 Apr; 56(2):138-41. PubMed ID: 12825414
[TBL] [Abstract][Full Text] [Related]
15. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial activity of meropenem against main bacterial species isolated from patient blood in 2006].
Kobayashi Y; Sumitani Y; Sugita K; Katohno Y
Jpn J Antibiot; 2007 Dec; 60(6):378-86. PubMed ID: 18447207
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Watanabe K; Kobayashi Y; Matsukawa M; Uchida H; Kunishima Y; Hirose T; Matsuda S; Sato S; Shigeta S; Fujime M; Fujita K; Yamaguti O; Ogihara M; Ishibashi K; Igari J; Takahashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Furuya N; Kashitani F; Murai M; Ooe H; Nishikawa M; Kumon H; Monden K; Oka T; Kitamura M; Kohno S; Tomono K; Miyazaki Y; Matsuoka Y; Fukuhara Y; Hirakata Y; Aoki S
Jpn J Antibiot; 2003 Oct; 56(5):396-423. PubMed ID: 14692378
[TBL] [Abstract][Full Text] [Related]
19. [A comparison of susceptibility of Pseudomonas aeruginosa clinical isolates to carbapenem antibiotics in our hospital].
Kakeya H; Yamada K; Nakaie K; Takizawa E; Okada Y; Fujita A; Nakamura Y; Abe J; Hirose A; Kaneko Y; Hino M
Jpn J Antibiot; 2014 Aug; 67(4):241-8. PubMed ID: 25420320
[TBL] [Abstract][Full Text] [Related]
20. [Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
Igari J; Inoue M; Nishino T; Watanabe N; Uehara N; Yoshida H; Imafuku Y; Shibano T; Satou S; Kobayashi I; Takahashi A; Yomoda S; Oguri T; Kumasaka K; Okada J; Hirata Y; Uchida K; Kawaguchi R; Ohtaki Y; Ishigo S; Okamoto E; Murakami E; Matsuoka K; Tokuda K; Saeki H
Jpn J Antibiot; 1997 Aug; 50(8):683-703. PubMed ID: 9339395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
